Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 2
2014 3
2015 9
2016 7
2017 5
2018 1
2020 1
2021 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean runazzo m [au] prostate (15 results)?
Das Prostatakarzinom: aktuelle Diagnostik und Therapiestandard.
Brachlow J, Kälin M, Randazzo M, Förster B, John H. Brachlow J, et al. Among authors: randazzo m. Praxis (Bern 1994). 2016 Aug;105(16):971-7. doi: 10.1024/1661-8157/a002437. Praxis (Bern 1994). 2016. PMID: 27524169 Review. German. No abstract available.
Magnetic resonance imaging in prostate cancer detection and management: a systematic review.
Monni F, Fontanella P, Grasso A, Wiklund P, Ou YC, Randazzo M, Rocco B, Montanari E, Bianchi G. Monni F, et al. Among authors: randazzo m. Minerva Urol Nefrol. 2017 Dec;69(6):567-578. doi: 10.23736/S0393-2249.17.02819-3. Epub 2017 May 8. Minerva Urol Nefrol. 2017. PMID: 28488844 Free article.
INTRODUCTION: The aim of our work was to evaluate the role of multi-parametric magnetic resonance imaging (mpMRI) in detection and management of prostate cancer (PC); specifically investigating the efficacy of mpMRI-based biopsy techniques in terms of diagnostic yield of s …
INTRODUCTION: The aim of our work was to evaluate the role of multi-parametric magnetic resonance imaging (mpMRI) in detection and managemen …
Limitations of Elastography Based Prostate Biopsy.
Schiffmann J, Grindei M, Tian Z, Yassin DJ, Steinwender T, Leyh-Bannurah SR, Randazzo M, Kwiatkowski M, Karakiewicz PI, Hammerer P, Manka L. Schiffmann J, et al. Among authors: randazzo m. J Urol. 2016 Jun;195(6):1731-6. doi: 10.1016/j.juro.2015.12.086. Epub 2016 Jan 6. J Urol. 2016. PMID: 26767519
PURPOSE: The role of elastography in patients initially and at repeat prostate biopsy is still indeterminate. The existing literature is sparse and controversial. ...Each prostate sextant was considered an individual case. The sensitivity, specificity, positive and …
PURPOSE: The role of elastography in patients initially and at repeat prostate biopsy is still indeterminate. The existing literature …
A positive family history as a risk factor for prostate cancer in a population-based study with organised prostate-specific antigen screening: results of the Swiss European Randomised Study of Screening for Prostate Cancer (ERSPC, Aarau).
Randazzo M, Müller A, Carlsson S, Eberli D, Huber A, Grobholz R, Manka L, Mortezavi A, Sulser T, Recker F, Kwiatkowski M. Randazzo M, et al. BJU Int. 2016 Apr;117(4):576-83. doi: 10.1111/bju.13310. Epub 2015 Oct 6. BJU Int. 2016. PMID: 26332304 Free PMC article. Clinical Trial.
OBJECTIVE: To assess the value of a positive family history (FH) as a risk factor for prostate cancer incidence and grade among men undergoing organised prostate-specific antigen (PSA) screening in a population-based study. ...On multivariable analysis, age (hazard …
OBJECTIVE: To assess the value of a positive family history (FH) as a risk factor for prostate cancer incidence and grade among men u …
How are we going to train a generation of radiologists (and urologists) to read prostate MRI?
Puech P, Randazzo M, Ouzzane A, Gaillard V, Rastinehad A, Lemaitre L, Villers A. Puech P, et al. Among authors: randazzo m. Curr Opin Urol. 2015 Nov;25(6):522-35. doi: 10.1097/MOU.0000000000000217. Curr Opin Urol. 2015. PMID: 26375060 Free article. Review.
RECENT FINDINGS: Recently, professional guidelines have been published to provide technical and interpretation frameworks and harmonize multiparametric-MRI practice, but the question of physicians training in prostate multiparametric-MRI reading is still pending. What kind …
RECENT FINDINGS: Recently, professional guidelines have been published to provide technical and interpretation frameworks and harmonize mult …
Metastatic Prostate Cancer Incidence and Prostate-specific Antigen Testing: New Insights from the European Randomized Study of Screening for Prostate Cancer.
Buzzoni C, Auvinen A, Roobol MJ, Carlsson S, Moss SM, Puliti D, de Koning HJ, Bangma CH, Denis LJ, Kwiatkowski M, Lujan M, Nelen V, Paez A, Randazzo M, Rebillard X, Tammela TL, Villers A, Hugosson J, Schröder FH, Zappa M. Buzzoni C, et al. Among authors: randazzo m. Eur Urol. 2015 Nov;68(5):885-90. doi: 10.1016/j.eururo.2015.02.042. Epub 2015 Mar 16. Eur Urol. 2015. PMID: 25791513 Free PMC article. Clinical Trial.
BACKGROUND: The European Randomized Study of Screening for Prostate Cancer (ERSPC) has shown a 21% reduction in prostate cancer (PCa) mortality and a 1.6-fold increase in PCa incidence with prostate-specific antigen (PSA)-based screening (at 13 yr of follow-u …
BACKGROUND: The European Randomized Study of Screening for Prostate Cancer (ERSPC) has shown a 21% reduction in prostate cance …
Prostate cancer screening: and yet it moves!
Kwiatkowski M, Randazzo M, Kluth L, Manka L, Huber A, Recker F. Kwiatkowski M, et al. Among authors: randazzo m. Asian J Androl. 2015 May-Jun;17(3):437-8. doi: 10.4103/1008-682X.143310. Asian J Androl. 2015. PMID: 25532573 Free PMC article.
The debate of prostate cancer (PCa) screening has been shaped over decades. There is a plethora of articles in the literature supporting as well as declining prostate-specific antigen (PSA) screening. ...With the long-term results of the European Randomized Study of …
The debate of prostate cancer (PCa) screening has been shaped over decades. There is a plethora of articles in the literature support …
Clinical impact of prostate biopsy undergrading in an academic and community setting.
Mortezavi A, Keller EX, Poyet C, Hermanns T, Saba K, Randazzo M, Fankhauser CD, Wild PJ, Moch H, Sulser T, Eberli D. Mortezavi A, et al. Among authors: randazzo m. World J Urol. 2016 Oct;34(10):1481-90. doi: 10.1007/s00345-016-1788-4. Epub 2016 Mar 1. World J Urol. 2016. PMID: 26931560 Free article.
PURPOSE: To evaluate whether the rate of Gleason score (GS) upgrade on final pathology, the rate of positive surgical margins (PSM) and the rate of biochemical recurrence (BCR) after radical prostatectomy (RP) were different if prostate biopsy (PB) was graded by community …
PURPOSE: To evaluate whether the rate of Gleason score (GS) upgrade on final pathology, the rate of positive surgical margins (PSM) and the …
Design-corrected variation by centre in mortality reduction in the ERSPC randomised prostate cancer screening trial.
Hakama M, Moss SM, Stenman UH, Roobol MJ, Zappa M, Carlsson S, Randazzo M, Nelen V, Hugosson J. Hakama M, et al. Among authors: randazzo m. J Med Screen. 2017 Jun;24(2):98-103. doi: 10.1177/0969141316652174. Epub 2016 Aug 9. J Med Screen. 2017. PMID: 27510947 Free PMC article. Clinical Trial.
Objectives To calculate design-corrected estimates of the effect of screening on prostate cancer mortality by centre in the European Randomised Study of Screening for Prostate Cancer (ERSPC). Setting The ERSPC has shown a 21% reduction in prostate cancer mort …
Objectives To calculate design-corrected estimates of the effect of screening on prostate cancer mortality by centre in the European …
Absolute Effect of Prostate Cancer Screening: Balance of Benefits and Harms by Center within the European Randomized Study of Prostate Cancer Screening.
Auvinen A, Moss SM, Tammela TL, Taari K, Roobol MJ, Schröder FH, Bangma CH, Carlsson S, Aus G, Zappa M, Puliti D, Denis LJ, Nelen V, Kwiatkowski M, Randazzo M, Paez A, Lujan M, Hugosson J. Auvinen A, et al. Among authors: randazzo m. Clin Cancer Res. 2016 Jan 1;22(1):243-9. doi: 10.1158/1078-0432.CCR-15-0941. Epub 2015 Aug 19. Clin Cancer Res. 2016. PMID: 26289069 Free PMC article.
PURPOSE: The balance of benefits and harms in prostate cancer screening has not been sufficiently characterized. We related indicators of mortality reduction and overdetection by center within the European Randomized Study of Prostate Cancer Screening (ERSPC). EXPER …
PURPOSE: The balance of benefits and harms in prostate cancer screening has not been sufficiently characterized. We related indicator …
24 results